677 filings
Page 8 of 34
8-K
301 rgjijvxb8l
5 Apr 21
ProPhase Labs Reports Fourth Quarter and Full Year 2020 Financial Results
8:51am
8-K
b4e t9q3g3xz
17 Mar 21
Regulation FD Disclosure
11:57am
8-K
jdyncx77
1 Feb 21
Regulation FD Disclosure
8:35am
8-K
qsrqs26y1cu37ewy
20 Jan 21
ProPhase Labs Announces Proposed Public Offering of Common Stock
4:15pm
424B5
60amuk3xya3qk7de
20 Jan 21
Prospectus supplement for primary offering
9:21am
FWP
vcs3da9gpyvj8 06lrj
19 Jan 21
Free writing prospectus
12:00am
424B5
hszm9hh042956t0kg5fv
15 Jan 21
Prospectus supplement for primary offering
5:15pm
8-K
wl2a ayod63
15 Jan 21
Entry into a Material Definitive Agreement
7:46am
8-K
pjxsjf4q yk4wtg
7 Jan 21
ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
8:05am
424B5
ivepo
6 Jan 21
Prospectus supplement for primary offering
5:23pm
8-K/A
kzrko1sv
4 Jan 21
Financial Statements and Exhibits
4:30pm
8-K
399 fspmlhpycs3s7
16 Dec 20
Termination of a Material Definitive Agreement
4:30pm
8-K
vaabjun8bqqf3 pc
15 Dec 20
Departure of Directors or Certain Officers
4:30pm
8-K
x8t09
14 Dec 20
Changes in Registrant's Certifying Accountant
4:36pm
8-K
nh4cfj
14 Dec 20
ProPhase Labs Expands COVID-19 Testing Capacity with New 25,000 Square Feet Testing Facility in Garden City, New York
6:11am
NT 10-Q
mdyfda7 cwgj5fa6pkb
16 Nov 20
Notice of late quarterly filing
5:08pm
8-K
npxoko dw
16 Nov 20
ProPhase Labs Reports Financial Results
8:35am
8-K
b46csv4kw8t0lgoc33w5
10 Nov 20
Regulation FD Disclosure
8:35am